# Michael R. Zile

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michael-r-zile/

## Facts

| Field | Value |
| --- | --- |
| Citations | 65,097 |
| Field | Cardiovascular Function and Risk Factors |
| h-index | 123 |
| i10-index | 484 |
| Last Known Institution | Medical University of South Carolina |
| OpenAlex ID | https://openalex.org/A5047833899 |
| ORCID iD | 0000-0001-7076-221X |
| Works | 862 |

## Researcher papers

Showing 12 of 28.

- [Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure](https://scholariq.org/papers/angiotensin-neprilysin-inhibition-versus-enalapril-in-heart-failure/)
- [Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction](https://scholariq.org/papers/angiotensin-neprilysin-inhibition-in-heart-failure-with-preserved-ejection/)
- [Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction](https://scholariq.org/papers/irbesartan-in-patients-with-heart-failure-and-preserved-ejection-fraction/)
- [Diastolic Heart Failure — Abnormalities in Active Relaxation and Passive Stiffness of the Left Ventricle](https://scholariq.org/papers/diastolic-heart-failure-abnormalities-in-active-relaxation-and-passive-stiffness/)
- [New Concepts in Diastolic Dysfunction and Diastolic Heart Failure: Part I](https://scholariq.org/papers/new-concepts-in-diastolic-dysfunction-and-diastolic-heart-failure-part-i/)
- [The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial](https://scholariq.org/papers/the-angiotensin-receptor-neprilysin-inhibitor-lcz696-in-heart-failure-with/)
- [Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction](https://scholariq.org/papers/phenotype-specific-treatment-of-heart-failure-with-preserved-ejection-fraction/)
- [New Concepts in Diastolic Dysfunction and Diastolic Heart Failure: Part II](https://scholariq.org/papers/new-concepts-in-diastolic-dysfunction-and-diastolic-heart-failure-part-ii/)
- [Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity](https://scholariq.org/papers/tirzepatide-for-heart-failure-with-preserved-ejection-fraction-and-obesity/)
- [Impaired Systolic Function by Strain Imaging in Heart Failure With Preserved Ejection Fraction](https://scholariq.org/papers/impaired-systolic-function-by-strain-imaging-in-heart-failure-with-preserved/)
- [Myocardial Stiffness in Patients With Heart Failure and a Preserved Ejection Fraction](https://scholariq.org/papers/myocardial-stiffness-in-patients-with-heart-failure-and-a-preserved-ejection/)
- [Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure](https://scholariq.org/papers/angiotensin-receptor-neprilysin-inhibition-compared-with-enalapril-on-the-risk/)

## Researcher topics

- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiac Fibrosis and Remodeling](https://scholariq.org/topics/cardiac-fibrosis-and-remodeling/)
- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)

## Researcher university

- [Medical University of South Carolina](https://scholariq.org/institutions/medical-university-of-south-carolina/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.